MPN-111 SVR(脾脏体积减少)预测PAC (Pacritinib)而不是BAT(最佳可用治疗)的MF(骨髓纤维化)患者的OS(总生存期):persist2里程碑式OS分析

{"title":"MPN-111 SVR(脾脏体积减少)预测PAC (Pacritinib)而不是BAT(最佳可用治疗)的MF(骨髓纤维化)患者的OS(总生存期):persist2里程碑式OS分析","authors":"Helen O Ajufo, J. Bewersdorf, C. Harrison, F. Palandri, J. Mascarenhas, J. Palmer, A. Gerds, J. Kiladjian, Sarah Buckley, Andriy Derkach, K. Roman-Torres, R. Rampal","doi":"10.1016/s2152-2650(23)00629-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"56 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"POSTER: MPN-111 SVR (Spleen Volume Reduction) Predicts OS (Overall Survival) in MF (Myelofibrosis) Patients on PAC (Pacritinib) but Not BAT (Best Available Therapy): PERSIST-2 Landmark OS Analysis\",\"authors\":\"Helen O Ajufo, J. Bewersdorf, C. Harrison, F. Palandri, J. Mascarenhas, J. Palmer, A. Gerds, J. Kiladjian, Sarah Buckley, Andriy Derkach, K. Roman-Torres, R. Rampal\",\"doi\":\"10.1016/s2152-2650(23)00629-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10370,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"56 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2152-2650(23)00629-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)00629-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}